Alpha Tau to Participate in Five September Investor Conferences
The original release is unavailable here.
Story so far
Earlier from Alpha Tau Medical
- Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
- Alpha Tau to Present at Jefferies Global Healthcare Conference
- Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
- Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
- Alpha Tau to Participate in May Investor Conferences
Later from Alpha Tau Medical
- Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
- Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
- Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
- Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- Alpha Tau to Participate in December Investor Conferences
Follow Alpha Tau Medical into a list and get an email when it puts out news.
Follow Alpha Tau Medical